Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats. 2004

Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
Department of General Surgery, Gulhane Military Medical Academy, Etlik, Ankara, Turkey.

BACKGROUND Acute pancreatitis (AP) is a complex disease associated with significant complications and a high rate of mortality. Although several mechanisms are put forward, oxidative stress seems the most important early event in the pathophysiology of AP. Therefore, we evaluated the beneficial effects of N-acetylcysteine (NAC), a strong antioxidant, in experimental AP. METHODS Forty-nine Sprague-Dawley rats were used. Acute pancreatitis (AP) was induced by the intraductal infusion of sodium taurocholate. Rats were divided into seven groups (each containing seven rats): control, sham-operated (saline-treated, 3.5 and 12 h), non-treated AP (3.5 and 12 h) and NAC-treated AP (3.5 and 12 h). Treated rats received intraperitoneal (i.p.) NAC 1000 mg/kg 24 h before and just before the induction of pancreatitis. RESULTS Rats with AP had extensive parenchymal and fat necrosis and NAC treatment at 12 h reduced tissue necrosis significantly (P < 0.05). NAC treatment at 12 h reduced leukocytic infiltration significantly (P < 0.05). Edema and hemorrhage were significantly increased in the AP groups when compared to controls (P < 0.001). NAC treatment reduced edema and hemorrhage at both 3.5 and 12 h slightly but not significantly. The total pathological mean score was significantly increased in the AP groups (P < 0.05) and it was reduced by NAC treatment (P < 0.05). NAC treatment decreased plasma amylase and lipase levels significantly (P < 0.05). While glutathione peroxidase (GPx) activity of pancreatic tissue was similar in the NAC-treated and AP groups, hepatic tissue GPx activity was lower in the AP groups, and NAC treatment restored it (P < 0.05). NAC had no effect on pancreatic superoxide dismutase level. In the NAC-treated rats, the serum NO(2)/NO(3) (nitrite/nitrate) level was significantly increased in the 3.5-h group when compared to the respective AP group (P < 0.05). NAC treatment also significantly reduced the serum concentration of the lipid peroxidation product, malondialdehyde, at 12 h (P < 0.05). CONCLUSIONS NAC treatment had beneficial effects in sodium taurocholate-induced AP in rats. It reduced pancreatic tissue necrosis and lipid peroxidation. In our study, the mechanism underlying the beneficial effects of NAC seemed to be its antioxidant activity, either by increasing hepatic GPx activity, or by a direct scavenging effect on free radicals, thus enhancing the production of and/or inhibiting the degradation of nitric oxide.

UI MeSH Term Description Entries
D008049 Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3. Triacylglycerol Lipase,Tributyrinase,Triglyceride Lipase,Acid Lipase,Acid Lipase A,Acid Lipase B,Acid Lipase I,Acid Lipase II,Exolipase,Monoester Lipase,Triacylglycerol Hydrolase,Triglyceridase,Triolean Hydrolase,Hydrolase, Triacylglycerol,Hydrolase, Triolean,Lipase A, Acid,Lipase B, Acid,Lipase I, Acid,Lipase II, Acid,Lipase, Acid,Lipase, Monoester,Lipase, Triglyceride
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D002756 Cholagogues and Choleretics Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). Choleretics,Cholagogues,Cholagogues, Choleretics,Choleretics and Cholagogues,Hydrocholeretics
D005979 Glutathione Peroxidase An enzyme catalyzing the oxidation of 2 moles of GLUTATHIONE in the presence of HYDROGEN PEROXIDE to yield oxidized glutathione and water. Cytosolic Glutathione Peroxidase,Glutathione Lipoperoxidase,Selenoglutathione Peroxidase,Glutathione Peroxidase, Cytosolic,Lipoperoxidase, Glutathione,Peroxidase, Glutathione,Peroxidase, Selenoglutathione
D000111 Acetylcysteine The N-acetyl derivative of CYSTEINE. It is used as a mucolytic agent to reduce the viscosity of mucous secretions. It has also been shown to have antiviral effects in patients with HIV due to inhibition of viral stimulation by reactive oxygen intermediates. Mercapturic Acid,Acemuc,Acetabs,Acetylcystein AL,Acetylcystein Atid,Acetylcystein Heumann,Acetylcystein Trom,Acetylcysteine Hydrochloride,Acetylcysteine Sodium,Acetylcysteine Zinc,Acetylcysteine, (D)-Isomer,Acetylcysteine, (DL)-Isomer,Acetylcysteine, Monoammonium Salt,Acetylcysteine, Monosodium Salt,Acetylin,Acetyst,Acétylcystéine GNR,Airbron,Alveolex,Azubronchin,Bisolvon NAC,Bromuc,Broncho-Fips,Broncholysin,Broncoclar,Codotussyl,Cystamucil,Dampo Mucopect,Eurespiran,Exomuc,Fabrol,Fluimucil,Fluprowit,Frekatuss,Genac,Hoestil,Ilube,Jenacystein,Jenapharm,Lantamed,Larylin NAC,Lindocetyl,M-Pectil,Muciteran,Muco Sanigen,Mucomyst,Mucosil,Mucosol,Mucosolvin,N-Acetyl-L-cysteine,N-Acetylcysteine,NAC AL,NAC Zambon,Optipect Hustengetränk,Siccoral,Siran,Solmucol,acebraus,durabronchal,mentopin Acetylcystein,Acetylcystein, mentopin,Acid, Mercapturic,Broncho Fips,BronchoFips,Hustengetränk, Optipect,Hydrochloride, Acetylcysteine,M Pectil,MPectil,Monoammonium Salt Acetylcysteine,Monosodium Salt Acetylcysteine,Mucopect, Dampo,N Acetyl L cysteine,N Acetylcysteine,NAC, Bisolvon,Sanigen, Muco,Sodium, Acetylcysteine,Zambon, NAC,Zinc, Acetylcysteine
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
August 2010, Revista do Colegio Brasileiro de Cirurgioes,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
November 2009, Translational research : the journal of laboratory and clinical medicine,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
May 2014, Molecular medicine reports,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
June 2005, The Tohoku journal of experimental medicine,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
February 1991, The American journal of physiology,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
October 2013, Digestive diseases and sciences,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
January 2002, Pancreas,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
April 2018, Canadian journal of physiology and pharmacology,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
January 2005, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
Gokhan Yagci, and Husamettin Gul, and Abdurrahman Simsek, and Varol Buyukdogan, and Onder Onguru, and Nazif Zeybek, and Ahmet Aydin, and Mujdat Balkan, and Oguzhan Yildiz, and Dervis Sen
March 2020, International immunopharmacology,
Copied contents to your clipboard!